BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38716459)

  • 1. Impact of Respiratory Bacterial Findings on Patients with Chronic Pulmonary Aspergillosis.
    Cho HK; Moon SM; Kim HT; Shin B
    Int J Microbiol; 2024; 2024():1329884. PubMed ID: 38716459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization.
    Ohara S; Tazawa Y; Tanai C; Tanaka Y; Noda H; Horiuchi H; Usui K
    Respir Investig; 2016 Mar; 54(2):92-7. PubMed ID: 26879478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of chronic pulmonary aspergillosis.
    Ohba H; Miwa S; Shirai M; Kanai M; Eifuku T; Suda T; Hayakawa H; Chida K
    Respir Med; 2012 May; 106(5):724-9. PubMed ID: 22349065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Laboratory Features and Performance of an
    Zhu RS; Zhou LH; Cheng JH; Luo Y; Qiu WJ; Huang JT; Jiang YK; Zhao HZ; Wang X; Chen ZQ; Zhu LP
    Microbiol Spectr; 2023 Jun; 11(3):e0026423. PubMed ID: 37125929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Microbiological and Clinical Characteristics of Bacterial Infection in Patients with Pulmonary Infection.
    Duan T
    Comput Intell Neurosci; 2022; 2022():5607358. PubMed ID: 35755768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-level analysis of bacteria isolated from inpatients in respiratory departments in China.
    Tang X; Xiao M; Zhuo C; Xu Y; Zhong N
    J Thorac Dis; 2018 May; 10(5):2666-2675. PubMed ID: 29997928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the
    Li H; Rui Y; Zhou W; Liu L; He B; Shi Y; Su X
    Front Microbiol; 2019; 10():1438. PubMed ID: 31316486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological characteristics of patients with severe burns caused by blast and application of meta- genomics next-generation sequencing in the detection of pathogenic microorganisms].
    Luo RB; Huang M; Hu H; Zhang R; Han CM
    Zhonghua Shao Shang Za Zhi; 2021 Oct; 37(10):946-952. PubMed ID: 34689464
    [No Abstract]   [Full Text] [Related]  

  • 11. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study.
    Aguilar-Company J; Martín MT; Goterris-Bonet L; Martinez-Marti A; Sampol J; Roldán E; Almirante B; Ruiz-Camps I
    Mycoses; 2019 Sep; 62(9):765-772. PubMed ID: 31162731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.
    Yu Q; He J; Xing B; Li X; Qian H; Zhang H; Xu M; Peng H
    BMC Pulm Med; 2020 Apr; 20(1):89. PubMed ID: 32293386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.
    Takeda K; Imamura Y; Takazono T; Yoshida M; Ide S; Hirano K; Tashiro M; Saijo T; Kosai K; Morinaga Y; Nakamura S; Kurihara S; Tsukamoto M; Miyazaki T; Tashiro T; Kohno S; Yanagihara K; Izumikawa K
    Med Mycol; 2016 Feb; 54(2):120-7. PubMed ID: 26531100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease.
    Naito M; Kurahara Y; Yoshida S; Ikegami N; Kobayashi T; Minomo S; Tachibana K; Tsuyuguchi K; Hayashi S; Suzuki K
    Respir Investig; 2018 Jul; 56(4):326-331. PubMed ID: 29764749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of chronic pulmonary aspergillosis regarding time of tuberculosis diagnosis in Brazil.
    Volpe-Chaves CE; Venturini J; B Castilho S; S O Fonseca S; F Nunes T; T Cunha EA; M E Lima G; O Nunes M; P Vicentini A; V L Oliveira SM; Carvalho LR; Thompson L; P Mendes R; M M Paniago A
    Mycoses; 2022 Jul; 65(7):715-723. PubMed ID: 35524507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
    Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
    Shimada K; Terai T; Igari J; Inoue H; Nakadate T; Oguri T; Suwabe A; Obata R; Ikemoto H; Ohno I; Okada S; Hayashi K; Mori T; Nakano K; Arakawa M; Gejyo F; Igarashi K; Yokouchi H; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Kitamura N; Suga M; Suzuki Y; Karasawa Y; Tosaka M; Nakata K; Nakatani T; Kohno S; Tomono K; Miyazaki Y; Inagawa H; Hirakata Y; Aoki S; Matsuda J; Kudo K; Kobayashi N; Kinoshita T; Konosaki H; Nasu M; Nagai H; Kobayashi H; Kawai S; Takayasu S; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-
    Takeda K; Suzuki J; Watanabe A; Narumoto O; Kawashima M; Sasaki Y; Nagai H; Kamei K; Matsui H
    J Clin Microbiol; 2022 Feb; 60(2):e0201821. PubMed ID: 34878803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan.
    Akram W; Ejaz MB; Mallhi TH; Syed Sulaiman SAB; Khan AH
    PLoS One; 2021; 16(11):e0259766. PubMed ID: 34767589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.